Alterity Therapeutics (PRNAD) Total Non-Current Liabilities (2009 - 2025)

Alterity Therapeutics (PRNAD) has reported Total Non-Current Liabilities for 16 consecutive years, with $42980.1 the latest figure, recorded in Q4 2025.

• In Q4 2025, Total Non-Current Liabilities rose 52.43% year-over-year to $42980.1; the TTM figure through Dec 2025 stood at $42980.1 (up 52.43% YoY), while the FY2025 annual figure was $56707.2, up 65.75% from the prior year.
• Total Non-Current Liabilities came in at $42980.1 for Q4 2025 at Alterity Therapeutics, down from $56707.2 in the prior quarter.
• The five-year high for Total Non-Current Liabilities was $56707.2 in Q2 2025, with the low at -$1.2 million in Q2 2024.
• Average Total Non-Current Liabilities over 5 years is -$82282.5, with a median of $33909.0 recorded in 2022.
• Across the five-year window, Total Non-Current Liabilities soared 388.34% in 2021 and sank 93911.18% in 2024, its largest moves.
• Year by year, Total Non-Current Liabilities stood at $28873.4 in 2021, then rose by 7.74% to $31108.7 in 2022, then soared by 60.1% to $49804.0 in 2023, then slumped by 43.38% to $28197.3 in 2024, then jumped by 52.43% to $42980.1 in 2025.
• According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $42980.1, $56707.2, and $28197.3 for Q4 2025, Q2 2025, and Q4 2024 respectively.